XENDIOR Trademark

Trademark Overview

On Tuesday, November 29, 2011, a trademark application was filed for XENDIOR with the United States Patent and Trademark Office. The USPTO has given the XENDIOR trademark a serial number of 85482573. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 20, 2015. This trademark is owned by Pfizer Inc.. The XENDIOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
xendior

General Information

Serial Number85482573
Word MarkXENDIOR
Filing DateTuesday, November 29, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 20, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 24, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 5, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, July 20, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 20, 2015ABANDONMENT - NO USE STATEMENT FILED
Saturday, December 13, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 12, 2014EXTENSION 5 GRANTED
Tuesday, December 9, 2014EXTENSION 5 FILED
Tuesday, December 9, 2014TEAS EXTENSION RECEIVED
Thursday, June 5, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 4, 2014EXTENSION 4 GRANTED
Monday, June 2, 2014EXTENSION 4 FILED
Monday, June 2, 2014TEAS EXTENSION RECEIVED
Friday, November 15, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 14, 2013EXTENSION 3 GRANTED
Monday, November 4, 2013EXTENSION 3 FILED
Monday, November 4, 2013TEAS EXTENSION RECEIVED
Wednesday, June 19, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 18, 2013EXTENSION 2 GRANTED
Monday, May 20, 2013EXTENSION 2 FILED
Tuesday, June 18, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 20, 2013TEAS EXTENSION RECEIVED
Friday, December 14, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 12, 2012EXTENSION 1 GRANTED
Wednesday, December 12, 2012EXTENSION 1 FILED
Wednesday, December 12, 2012TEAS EXTENSION RECEIVED
Friday, November 16, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 19, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 24, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 24, 2012PUBLISHED FOR OPPOSITION
Wednesday, April 4, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 20, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 19, 2012ASSIGNED TO LIE
Thursday, March 1, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 23, 2012EXAMINER'S AMENDMENT ENTERED
Thursday, February 23, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 23, 2012EXAMINERS AMENDMENT E-MAILED
Thursday, February 23, 2012EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 21, 2012ASSIGNED TO EXAMINER
Monday, December 5, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 2, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

xendior preparations pharmaceutical dysfunction sexual pain cancer treatment diseases disorders diabetes